Brief introduction of Beijing First Biochemical Pharmaceutical Co., Ltd.

Adhering to the company philosophy of "life first", Beijing No.1 Biochemical Pharmaceutical Co., Ltd. provides high-quality pure biological drugs for the society, promotes the development of medical undertakings and benefits the health of the people. The company has made great efforts in participating in social welfare undertakings, observing business ethics, safeguarding the legitimate rights and interests of workers and protecting the ecological environment, and has achieved great success, which has been recognized by government departments and people from all walks of life.

Beijing No.1 Biochemical Pharmaceutical Co., Ltd. built a new production base in Huairou Industrial Zone in Beijing in 2005, covering an area of 80 mu, adjacent to 10 1 National Highway and Jingcheng Expressway. The newly-built production plant covers an area of 6,200 square meters, with workshops and central laboratories for producing tablets, granules, oral liquids, small-volume injections, capsules and freeze-dried powder injections. The annual output is 800 million tablets, 400 million capsules, 5 million bags of granules, 30 million oral liquids and 20 million freeze-dried powders. The equipment and facilities are all domestic leading products, and the plant facilities are good, the process layout is reasonable, and the clean plant meets the requirements of corresponding dosage forms and product cleanliness grades. Huairou District is a famous scenic spot and environmental protection demonstration area in Beijing. The air quality and drinking water quality are at an excellent level all the year round, and there is no pollution around the factory, which ensures a good external environment for drug production. From June 5, 2005 to 10, our company signed a strategic cooperation agreement with Capital Medical University and formally joined Beijing New Drug Technology Transfer Center. The company started trial production in March, 2006. After repeated and strict examination by GMP certification team, all the indexes of tablets, capsules, granules, pills, oral liquid and extraction workshop produced by First Biochemical Pharmaceutical Co., Ltd. met the requirements of national drug GMP certification, and officially passed GMP certification on April 19, 2006. The company's quality management system has reached a new level, which has also injected new impetus into the development of biopharmaceutical industry! First Biochemical Pharmaceutical Co., Ltd. has initially completed the transformation to a multi-dose and large-scale production mode that fully meets GMP requirements, and has truly achieved the integration with international certification standards in terms of product quality, standardized management and safe production.

Beijing No.1 Biochemical Pharmaceutical Co., Ltd. has a professional team, efficient management and cutting-edge technology to keep our products updated. Our product spleen amino peptide oral liquid-two-way immune function regulator; Testicular tablets-treating male premature ejaculation, impotence and neurasthenia; Pancreatin tablets-digestive aid; Thrombin-a hemostatic agent, mainly used for gastrointestinal bleeding; Compound bovine fetal liver extract tablets are mainly used for hepatitis and other diseases; Among them, thrombin won the satisfaction prize of national commonly used drugs, and was included in People's Republic of China (PRC) Pharmacopoeia (1995).

Beijing No.1 Biochemical Pharmaceutical Co., Ltd. has always adhered to the core values of "honesty and trustworthiness", adhered to the principle of "being honest with others and keeping promises", and abided by national laws and regulations on market access, market competition and market transaction order. Over the years, the annual inspection of enterprises has been above one level. The company's sales network covers more than 30 provinces, municipalities and autonomous regions, and has established business relations with more than 65,438+000 large pharmaceutical companies. There are more than 654.38 million retail terminals in China, and products are delivered to the terminal market in the fastest way through fast and smooth sales channels. The company is based on honesty and abides by the contract. The company signed more than 1000 contracts every year, and the contract performance rate reached 100%. It has been rated as a contract-abiding and trustworthy unit for many times.